Back to ALLIANCEBERNSTEIN L.P. ALLIANCEBERNSTEIN L.P.

ESPRESPR
28 quarters

Position history for ALLIANCEBERNSTEIN L.P.ALLIANCEBERNSTEIN L.P.'s holdings in ESPERION THERAPEUTICS INC NE

ALLIANCEBERNSTEIN L.P. holds 3.6M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $9.8M as of 2026-Q2. The position was increased (+1270.6% shares). ESPR represents 0.0% of ALLIANCEBERNSTEIN L.P.'s portfolio.

Current Value

$9.8M

Current Shares

3.6M

Total Value Change

+$8.6M

Total Shares Change

+3.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.6M
+1270.6%
$9.8M0.0%$3.16
45
2026-Q1
Unchanged
261,760
0.0%
$968,5120.0%$2.91
0
2025-Q4
Increased
261,760
+23.6%
$968,5120.0%$3.69
30
2025-Q3
Decreased
211,760
-24.3%
$561,1640.0%$2.64
0
2025-Q2
Increased
279,760
+75.7%
$275,3960.0%$0.99
35
2025-Q1
Unchanged
159,260
0.0%
$229,3340.0%$1.50
0
2024-Q4
Decreased
159,260
-12.6%
$350,3720.0%$2.15
0
2024-Q3
Unchanged
182,110
0.0%
$300,4820.0%$1.68
0
2024-Q2
New
182,110
-
$404,2840.0%$2.22
33
2023-Q2
Exited
0
-100.0%
$00.0%$1.34
0
2023-Q1
Increased
73,000
+33.7%
$116,0700.0%$1.67
19
2022-Q4
Increased
54,600
+27.1%
$340,1580.0%$6.23
29
2022-Q3
Increased
42,953
+16.7%
$288,0000.0%$6.84
27
2022-Q2
Increased
36,800
+30.0%
$234,0000.0%$6.67
29
2022-Q1
Unchanged
28,300
0.0%
$131,0000.0%$4.89
0
2021-Q4
Decreased
28,300
-0.9%
$142,0000.0%$4.96
0
2021-Q3
Unchanged
28,570
0.0%
$344,0000.0%$12.44
0
2021-Q2
Increased
28,570
+20.2%
$604,0000.0%$21.13
29
2021-Q1
Decreased
23,770
-20.9%
$667,0000.0%$27.44
0
2020-Q4
Unchanged
30,070
0.0%
$782,0000.0%$28.15
0
2020-Q3
Decreased
30,070
-17.1%
$1.1M0.0%$37.46
0
2020-Q2
Increased
36,270
+10.0%
$1.9M0.0%$47.64
28
2020-Q1
Unchanged
32,970
0.0%
$1M0.0%$33.98
0
2019-Q4
Decreased
32,970
-47.2%
$2M0.0%$59.82
0
2019-Q3
Unchanged
62,464
0.0%
$2.3M0.0%$37.78
0
2019-Q2
Increased
62,464
+126.6%
$2.9M0.0%$46.52
42
2019-Q1
Unchanged
27,570
0.0%
$1.1M0.0%$40.15
0
2018-Q4
New
27,570
-
$1.3M0.0%$44.17
35

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used